Profile Image
Kathy S. Albain Photo
Name
Kathy S. Albain
Degree
M.D.
Rank
Professor
Primary Department
Hematology/Oncology
Appointment Request
Request an Appointment
Specialties
Breast Cancer
Lung Cancer
Cancer Survivorship
Cancer in Seniors
Chemoprevention of Breast Cancer
Chemoprevention of Lung Cancer
Mesothelioma
Locations
Cardinal Bernardin Cancer Center
Certifications
American Board of Internal Medicine Subspecialty Medical Oncology
American Board of Internal Medicine
Education
Medical School
University of Michigan Medical School
Residencies
University of Illinois at Chicago Medical Center, Internal Medicine: General
Fellowships
University of Chicago Hospitals and Clinics, Internal Medicine: Hematology & Medical Oncology
Hobbies
Classical Music
Travel
Family/Friends
Reading
Pipe Organ
Hiking
Singing
Exercise
Publications
Hershman,D. L.; Unger,J. M.; Crew,K. D.; Till,C.; Greenlee,H.; Minasian,L. M.; Moinpour,C. M.; Lew,D. L.; Fehrenbacher,L.; Wade,J. L.,3rd; Wong,S. F.; Fisch,M. J.; Lynn Henry,N.; Albain,K. S.Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715) Journal of the National Cancer Institute 2018 ; :
Cheng,T. D.; Darke,A. K.; Redman,M. W.; Zirpoli,G. R.; Davis,W.; Payne Ondracek,R.; Bshara,W.; Omilian,A. R.; Kratzke,R.; Reid,M. E.; Molina,J. R.; Kolesar,J. M.; Chen,Y.; MacRae,R. M.; Moon,J.; Mack,P.; Gandara,D. R.; Kelly,K.; Santella,R. M.; Albain,K. S.; Ambrosone,C. B.Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424) Journal of the National Cancer Institute 2018 ; :
Sucheston-Campbell,L. E.; Clay-Gilmour,A. I.; Barlow,W. E.; Budd,G. T.; Stram,D. O.; Haiman,C. A.; Sheng,X.; Yan,L.; Zirpoli,G.; Yao,S.; Jiang,C.; Owzar,K.; Hershman,D.; Albain,K. S.; Hayes,D. F.; Moore,H. C.; Hobday,T. J.; Stewart,J. A.; Rizvi,A.; Isaacs,C.; Salim,M.; Gralow,J. R.; Hortobagyi,G. N.; Livingston,R. B.; Kroetz,D. L.; Ambrosone,C. B.Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci Pharmacogenetics and Genomics 2018 ;28(2):49-55
Zirpoli,G. R.; McCann,S. E.; Sucheston-Campbell,L. E.; Hershman,D. L.; Ciupak,G.; Davis,W.; Unger,J. M.; Moore,H. C. F.; Stewart,J. A.; Isaacs,C.; Hobday,T. J.; Salim,M.; Hortobagyi,G. N.; Gralow,J. R.; Budd,G. T.; Albain,K. S.; Ambrosone,C. B.Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study Journal of the National Cancer Institute 2017 ;109(12):10.1093/jnci/djx098
Crew,K. D.; Albain,K. S.; Hershman,D. L.; Unger,J. M.; Lo,S. S.How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? NPJ breast cancer 2017 ;3:20-017-0021-y. eCollection 2017
Park,J. W.; Liu,M. C.; Yee,D.; Yau,C.; van 't Veer,L. J.; Symmans,W. F.; Paoloni,M.; Perlmutter,J.; Hylton,N. M.; Hogarth,M.; DeMichele,A.; Buxton,M. B.; Chien,A. J.; Wallace,A. M.; Boughey,J. C.; Haddad,T. C.; Chui,S. Y.; Kemmer,K. A.; Kaplan,H. G.; Isaacs,C.; Nanda,R.; Tripathy,D.; Albain,K. S.; Edmiston,K. K.; Elias,A. D.; Northfelt,D. W.; Pusztai,L.; Moulder,S. L.; Lang,J. E.; Viscusi,R. K.; Euhus,D. M.; Haley,B. B.; Khan,Q. J.; Wood,W. C.; Melisko,M.; Schwab,R.; Helsten,T.; Lyandres,J.; Davis,S. E.; Hirst,G. L.; Sanil,A.; Esserman,L. J.; Berry,D. A.; I-SPY 2 InvestigatorsAdaptive Randomization of Neratinib in Early Breast Cancer The New England journal of medicine 2016 ;375(1):11-22
Potkul,R. K.; Unger,J. M.; Livingston,R. B.; Crew,K. D.; Wilczynski,S. P.; Salomon,C. G.; Smith,B. L.; Wong,L.; Campbell,D. L.; Einspahr,D. E.; Anderson,G. L.; Hershman,D.; Goodman,G. E.; Brown,P. H.; Meyskens,F. L.; Albain,K. S.Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630 NPJ breast cancer 2016 ;2:16024
Hertz,D. L.; Barlow,W. E.; Kidwell,K. M.; Albain,K. S.; Vandenberg,T. A.; Dakhil,S. R.; Tirumali,N. R.; Livingston,R. B.; Gralow,J.; Hayes,D. F.; Hortobagyi,G. N.; Mehta,R. S.; Rae,J. M.Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2016 ; :
Rugo,H. S.; Olopade,O. I.; DeMichele,A.; Yau,C.; van 't Veer,L. J.; Buxton,M. B.; Hogarth,M.; Hylton,N. M.; Paoloni,M.; Perlmutter,J.; Symmans,W. F.; Yee,D.; Chien,A. J.; Wallace,A. M.; Kaplan,H. G.; Boughey,J. C.; Haddad,T. C.; Albain,K. S.; Liu,M. C.; Isaacs,C.; Khan,Q. J.; Lang,J. E.; Viscusi,R. K.; Pusztai,L.; Moulder,S. L.; Chui,S. Y.; Kemmer,K. A.; Elias,A. D.; Edmiston,K. K.; Euhus,D. M.; Haley,B. B.; Nanda,R.; Northfelt,D. W.; Tripathy,D.; Wood,W. C.; Ewing,C.; Schwab,R.; Lyandres,J.; Davis,S. E.; Hirst,G. L.; Sanil,A.; Berry,D. A.; Esserman,L. J.; I-SPY 2 InvestigatorsAdaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer The New England journal of medicine 2016 ;375(1):23-34
Budd,G. T.; Barlow,W. E.; Moore,H. C.; Hobday,T. J.; Stewart,J. A.; Isaacs,C.; Salim,M.; Cho,J. K.; Rinn,K. J.; Albain,K. S.; Chew,H. K.; Burton,G. V.; Moore,T. D.; Srkalovic,G.; McGregor,B. A.; Flaherty,L. E.; Livingston,R. B.; Lew,D. L.; Gralow,J. R.; Hortobagyi,G. N.SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 ;33(1):58-64
Tolaney,S. M.; Barry,W. T.; Dang,C. T.; Yardley,D. A.; Moy,B.; Marcom,P. K.; Albain,K. S.; Rugo,H. S.; Ellis,M.; Shapira,I.; Wolff,A. C.; Carey,L. A.; Overmoyer,B. A.; Partridge,A. H.; Guo,H.; Hudis,C. A.; Krop,I. E.; Burstein,H. J.; Winer,E. P.Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer The New England journal of medicine 2015 ;372(2):134-141
Moore,H. C.; Unger,J. M.; Phillips,K. A.; Boyle,F.; Hitre,E.; Porter,D.; Francis,P. A.; Goldstein,L. J.; Gomez,H. L.; Vallejos,C. S.; Partridge,A. H.; Dakhil,S. R.; Garcia,A. A.; Gralow,J.; Lombard,J. M.; Forbes,J. F.; Martino,S.; Barlow,W. E.; Fabian,C. J.; Minasian,L.; Meyskens,F. L.,Jr; Gelber,R. D.; Hortobagyi,G. N.; Albain,K. S.; POEMS/S0230 InvestigatorsGoserelin for ovarian protection during breast-cancer adjuvant chemotherapy The New England journal of medicine 2015 ;372(10):923-932
DeMichele,A.; Yee,D.; Berry,D. A.; Albain,K. S.; Benz,C. C.; Boughey,J.; Buxton,M.; Chia,S. K.; Chien,A. J.; Chui,S. Y.; Clark,A.; Edmiston,K.; Elias,A.; Forero-Torres,A.; Haddad,T. C.; Haley,B.; Haluska,P.; Hylton,N. M.; Isaacs,C.; Kaplan,H.; Korde,L. A.; Leyland-Jones,B.; Liu,M. C.; Melisko,M.; Minton,S. E.; Moulder,S.; Nanda,R.; Olopade,O. I.; Paoloni,M.; Park,J. W.; Parker,B. A.; Perlmutter,J.; Petricoin,E.,3rd; Rugo,H. S.; Symmans,W. F.; Tripathy,D.; van 't Veer,L. J.; Viscusi,R. K.; Wallace,A.; Wolf,D.; Yau,C.; Esserman,L. J.The Neoadjuvant Model is Still the Future for Drug Development in Breast Cancer Clinical cancer research : an official journal of the American Association for Cancer Research 2015 ;21(13):2911-2915
Dang,C.; Guo,H.; Najita,J.; Yardley,D.; Marcom,K.; Albain,K.; Rugo,H.; Miller,K.; Ellis,M.; Shapira,I.; Wolff,A. C.; Carey,L. A.; Moy,B.; Groarke,J.; Moslehi,J.; Krop,I.; Burstein,H. J.; Hudis,C.; Winer,E. P.; Tolaney,S. M.Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer JAMA oncology 2015 ; :1-8
Pandya,K.; Wyatt,D.; Gallagher,B.; Shah,D.; Baker,A.; Bloodworth,J.; Zlobin,A.; Pannuti,A.; Green,A.; Ellis,I. O.; Filipovic,A.; Sagert,J.; Rana,A.; Albain,K. S.; Miele,L.; Denning,M. F.; Osipo,C.PKCalpha Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance Clinical cancer research : an official journal of the American Association for Cancer Research 2015 ; :
Unger,J. M.; Gralow,J. R.; Albain,K. S.; Ramsey,S. D.; Hershman,D. L.Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study JAMA oncology 2015 ; :1-3
Sparano,J. A.; Gray,R. J.; Makower,D. F.; Pritchard,K. I.; Albain,K. S.; Hayes,D. F.; Geyer,C. E.,Jr; Dees,E. C.; Perez,E. A.; Olson,J. A.,Jr; Zujewski,J.; Lively,T.; Badve,S. S.; Saphner,T. J.; Wagner,L. I.; Whelan,T. J.; Ellis,M. J.; Paik,S.; Wood,W. C.; Ravdin,P.; Keane,M. M.; Gomez Moreno,H. L.; Reddy,P. S.; Goggins,T. F.; Mayer,I. A.; Brufsky,A. M.; Toppmeyer,D. L.; Kaklamani,V. G.; Atkins,J. N.; Berenberg,J. L.; Sledge,G. W.Prospective Validation of a 21-Gene Expression Assay in Breast Cancer The New England journal of medicine 2015 ; :
Hannick,J. H.; Wang,L.; Barkan,G. A.; Perez,C.; Bova,D.; Albain,K. S.; Quek,M. L.Positron emission tomography-avid adrenal mass and incidental renal mass in a 70-year-old woman with newly diagnosed breast cancer Urology 2014 ;83(1):18-21
Miller,K. D.; Dieras,V.; Harbeck,N.; Andre,F.; Mahtani,R. L.; Gianni,L.; Albain,K. S.; Crivellari,D.; Fang,L.; Michelson,G.; de Haas,S. L.; Burris,H. A.Phase IIa trial of trastuzumab emtansine with pertuzumab for patients with human epidermal growth factor receptor 2-positive, locally advanced, or metastatic breast cancer Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 ;32(14):1437-1444
Hershman,D. L.; Unger,J. M.; Crew,K. D.; Minasian,L. M.; Awad,D.; Moinpour,C. M.; Hansen,L.; Lew,D. L.; Greenlee,H.; Fehrenbacher,L.; Wade,J. L.,3rd; Wong,S. F.; Hortobagyi,G. N.; Meyskens,F. L.; Albain,K. S.Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 ;31(20):2627-33
Unger,J. M.; Hershman,D. L.; Albain,K. S.; Moinpour,C. M.; Petersen,J. A.; Burg,K.; Crowley,J. J.Patient income level and cancer clinical trial participation Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 ;31(5):536-542
Zirpoli,G. R.; Brennan,P. M.; Hong,C. C.; McCann,S. E.; Ciupak,G.; Davis,W.; Unger,J. M.; Budd,G. T.; Hershman,D. L.; Moore,H. C.; Stewart,J.; Isaacs,C.; Hobday,T.; Salim,M.; Hortobagyi,G. N.; Gralow,J. R.; Albain,K. S.; Ambrosone,C. B.Supplement use during an intergroup clinical trial for breast cancer (S0221) Breast cancer research and treatment 2013 ;137(3):903-913
DeMichele,A.; Berry,D. A.; Zujewski,J.; Hunsberger,S.; Rubinstein,L.; Tomaszewski,J. E.; Kelloff,G.; Perlmutter,J.; Buxton,M.; Lyandres,J.; Albain,K. S.; Benz,C.; Chien,A. J.; Haluska,P.; Leyland-Jones,B.; Liu,M. C.; Munster,P.; Olopade,O.; Park,J. W.; Parker,B. A.; Pusztai,L.; Tripathy,D.; Rugo,H.; Yee,D.; Esserman,L.Developing safety criteria for introducing new agents into neoadjuvant trials Clinical cancer research : an official journal of the American Association for Cancer Research 2013 ;19(11):2817-2823
Schott,A. F.; Barlow,W. E.; Albain,K. S.; Chew,H. K.; Wade,J. L.,3rd; Lanier,K. S.; Lew,D. L.; Hayes,D. F.; Gralow,J. R.; Livingston,R. B.; Hortobagyi,G. N.Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430 The oncologist 2012 ;17(2):179-187
Burstein,H. J.; Piccart-Gebhart,M. J.; Perez,E. A.; Hortobagyi,G. N.; Wolmark,N.; Albain,K. S.; Norton,L.; Winer,E. P.; Hudis,C. A.Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 ;30(18):2179-2182
Kindler,H. L.; Karrison,T. G.; Gandara,D. R.; Lu,C.; Krug,L. M.; Stevenson,J. P.; Janne,P. A.; Quinn,D. I.; Koczywas,M. N.; Brahmer,J. R.; Albain,K. S.; Taber,D. A.; Armato,S. G.,3rd; Vogelzang,N. J.; Chen,H. X.; Stadler,W. M.; Vokes,E. E.Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 ;30(20):2509-2515
Mehta,R. S.; Barlow,W. E.; Albain,K. S.; Vandenberg,T. A.; Dakhil,S. R.; Tirumali,N. R.; Lew,D. L.; Hayes,D. F.; Gralow,J. R.; Livingston,R. B.; Hortobagyi,G. N.Combination anastrozole and fulvestrant in metastatic breast cancer The New England journal of medicine 2012 ;367(5):435-444
Moinpour,C. M.; Donaldson,G. W.; Liepa,A. M.; Melemed,A. S.; O'Shaughnessy,J.; Albain,K. S.Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012 ;21(5):765-775
Javid,S. H.; Unger,J. M.; Gralow,J. R.; Moinpour,C. M.; Wozniak,A. J.; Goodwin,J. W.; Lara,P. N.,Jr; Williams,P. A.; Hutchins,L. F.; Gotay,C. C.; Albain,K. S.A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316) The oncologist 2012 ;17(9):1180-1190
Sucheston,L. E.; Zhao,H.; Yao,S.; Zirpoli,G.; Liu,S.; Barlow,W. E.; Moore,H. C.; Thomas Budd,G.; Hershman,D. L.; Davis,W.; Ciupak,G. L.; Stewart,J. A.; Isaacs,C.; Hobday,T. J.; Salim,M.; Hortobagyi,G. N.; Gralow,J. R.; Livingston,R. B.; Albain,K. S.; Hayes,D. F.; Ambrosone,C. B.Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221) Breast cancer research and treatment 2011 ;130(3):993-1002
Lo,S. S.; Albain,K. S.Impact of Multigene Assays in Early Stage Breast Cancer Oncologist 2011 ;16(11):1482-1483
Livingston,R. B.; Barlow,W. E.; Kash,J. J.; Albain,K. S.; Gralow,J. R.; Lew,D. L.; Flaherty,L. E.; Royce,M. E.; Hortobagyi,G. N.SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer Breast cancer research and treatment 2011 ;130(1):123-131
Albain,K. S.Commentary on adjuvant chemotherapy for the older woman with early stage breast cancer Breast (Edinburgh, Scotland) 2011 ;20 Suppl 3:S150-2
Pandya,K.; Meeke,K.; Clementz,A. G.; Rogowski,A.; Roberts,J.; Miele,L.; Albain,K. S.; Osipo,C.Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence. British journal of cancer 2011 ;105(6):796-806
Gervais,R.; Hainsworth,J. D.; Blais,N.; Besse,B.; Laskin,J.; Hamm,J. T.; Lipton,A.; Albain,K. S.; Masters,G. A.; Natale,R. B.; Selaru,P.; Kim,S. T.; Chao,R. C.; Page,R. D.Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer Lung cancer (Amsterdam, Netherlands) 2011 ;74(3):474-480
Grudzien,P.; Lo,S.; Albain,K. S.; Robinson,P.; Rajan,P.; Strack,P. R.; Golde,T. E.; Miele,L.; Foreman,K. E.Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Anticancer Research 2010 ;30(10):3853-3867
Lo,S. S.; Mumby,P. B.; Norton,J.; Rychlik,K.; Smerage,J.; Kash,J.; Chew,H. K.; Gaynor,E. R.; Hayes,D. F.; Epstein,A.; Albain,K. S.Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. Journal of Clinical Oncology 2010 ;28(10):1671-1676
Herbst,R. S.; Kelly,K.; Chansky,K.; Mack,P. C.; Franklin,W. A.; Hirsch,F. R.; Atkins,J. N.; Dakhil,S. R.; Albain,K. S.; Kim,E. S.; Redman,M.; Crowley,J. J.; Gandara,D. R.Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342 Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(31):4747-4754
Burnell,M.; Levine,M. N.; Chapman,J. A.; Bramwell,V.; Gelmon,K.; Walley,B.; Vandenberg,T.; Chalchal,H.; Albain,K. S.; Perez,E. A.; Rugo,H.; Pritchard,K.; O'Brien,P.; Shepherd,L. E.Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(1):77-82
Yao,S.; Barlow,W. E.; Albain,K. S.; Choi,J. Y.; Zhao,H.; Livingston,R. B.; Davis,W.; Rae,J. M.; Yeh,I. T.; Hutchins,L. F.; Ravdin,P. M.; Martino,S.; Lyss,A. P.; Osborne,C. K.; Abeloff,M.; Hortobagyi,G. N.; Hayes,D. F.; Ambrosone,C. B.Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer Clinical cancer research : an official journal of the American Association for Cancer Research 2010 ;16(24):6169-6176
Yao,S.; Barlow,W. E.; Albain,K. S.; Choi,J. Y.; Zhao,H.; Livingston,R. B.; Davis,W.; Rae,J. M.; Yeh,I. T.; Hutchins,L. F.; Ravdin,P. M.; Martino,S.; Lyss,A. P.; Osborne,C. K.; Abeloff,M. D.; Hortobagyi,G. N.; Hayes,D. F.; Ambrosone,C. B.Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer Breast cancer research and treatment 2010 ;124(2):433-439
Albain,K. S.; Barlow,W. E.; Shak,S.; Hortobagyi,G. N.; Livingston,R. B.; Yeh,I. T.; Ravdin,P.; Bugarini,R.; Baehner,F. L.; Davidson,N. E.; Sledge,G. W.; Winer,E. P.; Hudis,C.; Ingle,J. N.; Perez,E. A.; Pritchard,K. I.; Shepherd,L.; Gralow,J. R.; Yoshizawa,C.; Allred,D. C.; Osborne,C. K.; Hayes,D. F.Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncology 2010 ;11(1):55-65
Albain,K. S.; Carey,L.; Gradishar,W. J.; Gralow,J. R.; Lipton,A.; Rugo,H.; Tripathy,D.; Peck,S.; Abair,T.; Pegram,M.Proceedings of the first global workshop on breast cancer: pathways to the evaluation and clinical development of novel agents for breast cancer Clinical Breast Cancer 2010 ;10(6):421-439
Leighl,N. B.; Raez,L. E.; Besse,B.; Rosen,P. J.; Barlesi,F.; Massarelli,E.; Gabrail,N.; Hart,L. L.; Albain,K. S.; Berkowitz,L.; Melnyk,O.; Shepherd,F. A.; Sternas,L.; Ackerman,J.; Shun,Z.; Miller,V. A.; Herbst,R. S.A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 ;5(7):1054-1059
Slovak,M. L.; Bedell,V.; Lew,D.; Albain,K. S.; Ellis,G. K.; Livingston,R. B.; Martino,S.; Perez,E. A.; Hortobagyi,G. N.; Sher,D.; Stock,W.Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012) Breast cancer research and treatment 2010 ;119(2):391-398
Tubbs,R.; Barlow,W. E.; Budd,G. T.; Swain,E.; Porter,P.; Gown,A.; Yeh,I. T.; Sledge,G.; Shapiro,C.; Ingle,J.; Haskell,C.; Albain,K. S.; Livingston,R.; Hayes,D. F.Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 ;27(24):3881-3886
Ambrosone,C. B.; Barlow,W. E.; Reynolds,W.; Livingston,R. B.; Yeh,I. T.; Choi,J. Y.; Davis,W.; Rae,J. M.; Tang,L.; Hutchins,L. R.; Ravdin,P. M.; Martino,S.; Osborne,C. K.; Lyss,A. P.; Hayes,D. F.; Albain,K. S.Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897 Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 ;27(30):4973-4979
Shafer,D.; Albain,K.Lung cancer outcomes in women. Seminars in oncology 2009 ;36(6):532-541
Albain,K. S.; Swann,R. S.; Rusch,V. W.; Turrisi,A. T.,3rd; Shepherd,F. A.; Smith,C.; Chen,Y.; Livingston,R. B.; Feins,R. H.; Gandara,D. R.; Fry,W. A.; Darling,G.; Johnson,D. H.; Green,M. R.; Miller,R. C.; Ley,J.; Sause,W. T.; Cox,J. D.Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 2009 ;374(9687):379-386
Gabram,S. G.; Dougherty,T.; Albain,K. S.; Klein,K.; Mumby,P.; Lee,K.; Yao,K.; Krishnamachari,B.; Salibay,C. J.; Lund,M. J.Assessing breast cancer risk and providing treatment recommendations: immediate impact of an educational session The breast journal 2009 ;15 Suppl 1:S39-45
Chew,H. K.; Doroshow,J. H.; Frankel,P.; Margolin,K. A.; Somlo,G.; Lenz,H. J.; Gordon,M.; Zhang,W.; Yang,D.; Russell,C.; Spicer,D.; Synold,T.; Bayer,R.; Hantel,A.; Stiff,P. J.; Tetef,M. L.; Gandara,D. R.; Albain,K. S.Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 ;27(13):2163-2169
Cardoso,F.; Bedard,P. L.; Winer,E. P.; Pagani,O.; Senkus-Konefka,E.; Fallowfield,L. J.; Kyriakides,S.; Costa,A.; Cufer,T.; Albain,K. S.; ESO-MBC Task ForceInternational guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy Journal of the National Cancer Institute 2009 ;101(17):1174-1181
Davies,A. M.; Chansky,K.; Lara,P. N.,Jr; Gumerlock,P. H.; Crowley,J.; Albain,K. S.; Vogel,S. J.; Gandara,D. R.; Southwest Oncology GroupBortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339) Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009 ;4(1):87-92
Choi,J. Y.; Barlow,W. E.; Albain,K. S.; Hong,C. C.; Blanco,J. G.; Livingston,R. B.; Davis,W.; Rae,J. M.; Yeh,I. T.; Hutchins,L. F.; Ravdin,P. M.; Martino,S.; Lyss,A. P.; Osborne,C. K.; Abeloff,M. D.; Hayes,D. F.; Ambrosone,C. B.Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial Clinical cancer research : an official journal of the American Association for Cancer Research 2009 ;15(16):5258-5266
Lo,S. S.; Pritchard,K. I.; Robinson,P.; Albain,K. S.Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings Cancer treatment and research 2009 ;147:1-29
Albain,K. S.; Unger,J. M.; Crowley,J. J.; Coltman,C. A.,Jr; Hershman,D. L.Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group Journal of the National Cancer Institute 2009 ;101(14):984-992
Albain,K. S.; Barlow,W. E.; Ravdin,P. M.; Farrar,W. B.; Burton,G. V.; Ketchel,S. J.; Cobau,C. D.; Levine,E. G.; Ingle,J. N.; Pritchard,K. I.; Lichter,A. S.; Schneider,D. J.; Abeloff,M. D.; Henderson,I. C.; Muss,H. B.; Green,S. J.; Lew,D.; Livingston,R. B.; Martino,S.; Osborne,C. K.Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial Lancet 2009 ;374(9707):2055-2063
Albain,K. S.; Paik,S.; van't Veer,L.Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays Breast 2009 ;18(Suppl 3):S141-5
Albain,K. S.; Nag,S. M.; Calderillo-Ruiz,G.; Jordaan,J. P.; Llombart,A. C.; Pluzanska,A.; Rolski,J.; Melemed,A. S.; Reyes-Vidal,J. M.; Sekhon,J. S.; Simms,L.; O'Shaughnessy,J.Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment. Journal of Clinical Oncology 2008 ;26(24):3950-3957
Rizzo,P.; Miao,H.; D'Souza,G.; Osipo,C.; Song,L. L.; Yun,J.; Zhao,H.; Mascarenhas,J.; Wyatt,D.; Antico,G.; Hao,L.; Yao,K.; Rajan,P.; Hicks,C.; Siziopikou,K.; Selvaggi,S.; Bashir,A.; Bhandari,D.; Marchese,A.; Lendahl,U.; Qin,J. Z.; Tonetti,D. A.; Albain,K.; Nickoloff,B. J.; Miele,L.Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches Cancer research 2008 ;68(13):5226-5235
Camacho,P. M.; Dayal,A. S.; Diaz,J. L.; Nabhan,F. A.; Agarwal,M.; Norton,J. G.; Robinson,P. A.; Albain,K. S.Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis. Journal of Clinical Oncology 2008 ;26(33):5380-5385
Ganz,P. A.; Hussey,M. A.; Moinpour,C. M.; Unger,J. M.; Hutchins,L. F.; Dakhil,S. R.; Giguere,J. K.; Goodwin,J. W.; Martino,S.; Albain,K. S.Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897 Journal of Clinical Oncology 2008 ;26(8):1223-1230
Goodwin,J. W.; Green,S. J.; Moinpour,C. M.; Bearden,J. D.,3rd; Giguere,J. K.; Jiang,C. S.; Lippman,S. M.; Martino,S.; Albain,K. S.Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. Journal of Clinical Oncology 2008 ;26(10):1650-1656
Kelly,K.; Chansky,K.; Gaspar,L. E.; Albain,K. S.; Jett,J.; Ung,Y. C.; Lau,D. H.; Crowley,J. J.; Gandara,D. R.Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023 Journal of Clinical Oncology 2008 ;26(15):2450-2456
Swinnen,L. J.; Rankin,C.; Carraway,H.; Albain,K. S.; Townsend,J. J.; Budd,G. T.; Kish,J. A.; Rivkin,S. E.; Blumenthal,D. T.A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149). Journal of neuro-oncology 2008 ;86(3):353-358
Gotay,C. C.; Moinpour,C. M.; Unger,J. M.; Jiang,C. S.; Coleman,D.; Martino,S.; Parker,B. J.; Bearden,J. D.; Dakhil,S.; Gross,H. M.; Lippman,S.; Albain,K. S.Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence. Journal of Clinical Oncology 2007 ;25(15):2093-2099
Robert,N.; Leyland-Jones,B.; Asmar,L.; Belt,R.; Ilegbodu,D.; Loesch,D.; Raju,R.; Valentine,E.; Sayre,R.; Cobleigh,M.; Albain,K.; McCullough,C.; Fuchs,L.; Slamon,D.Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer. Journal of Clinical Oncology 2006 ;24(18):2786-2792
Guiahi,M.; Gabram,S. G.; Albain,K. S.; Camacho,P. M.; Krishnamachari,B.; Rajan,P.Clinical factors used to support prophylactic mastectomy for a male BRCA2 mutation carrier. Surgery 2006 ;139(5):704-706
Tanvetyanon,T.; Garrity,E. R.; Albain,K. S.Acute lung injury associated with vinorelbine. Journal of Clinical Oncology 2006 ;24(12):1952-1953
Albain,K. S.; Belani,C. P.; Bonomi,P.; O'Byrne,K. J.; Schiller,J. H.; Socinski,M.PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2. Clinical Lung Cancer 2006 ;7(6):417-419
Ambrosone,C. B.; Rebbeck,T. R.; Morgan,G. J.; Albain,K. S.; Calle,E. E.; Evans,W. E.; Hayes,D. F.; Kushi,L. H.; McLeod,H. L.; Rowland,J. H.; Ulrich,C. M.New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survival Cancer Epidemiology, Biomarkers & Prevention 2006 ;15(11):2042-2046
Unger,J. M.; Coltman,C. A.,Jr; Crowley,J. J.; Hutchins,L. F.; Martino,S.; Livingston,R. B.; Macdonald,J. S.; Blanke,C. D.; Gandara,D. R.; Crawford,E. D.; Albain,K. S.Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. Journal of Clinical Oncology 2006 ;24(1):141-144
West,K. E.; Wojcik,E. M.; Dougherty,T. A.; Siziopikou,K. P.; Albain,K. S.; Gabram,S. G.Correlation of nipple aspiration and ductal lavage cytology with histopathologic findings for patients before scheduled breast biopsy examination. American Journal of Surgery 2006 ;191(1):57-60
Gandara,D. R.; Chansky,K.; Albain,K. S.; Gaspar,L. E.; Lara,P. N.,Jr; Kelly,K.; Crowley,J.; Livingston,R.Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504). Clinical Lung Cancer 2006 ;8(2):116-121
Porter,P. L.; Barlow,W. E.; Yeh,I. T.; Lin,M. G.; Yuan,X. P.; Donato,E.; Sledge,G. W.; Shapiro,C. L.; Ingle,J. N.; Haskell,C. M.; Albain,K. S.; Roberts,J. M.; Livingston,R. B.; Hayes,D. F.p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy Journal of the National Cancer Institute 2006 ;98(23):1723-1731
Farray,D.; Mirkovic,N.; Albain,K. S.Multimodality therapy for stage III non-small-cell lung cancer.[erratum appears in J Clin Oncol. 2005 Oct 20;23(30):7763] Journal of Clinical Oncology 2005 ;23(14):3257-3269
Pierce,L. J.; Hutchins,L. F.; Green,S. R.; Lew,D. L.; Gralow,J. R.; Livingston,R. B.; Osborne,C. K.; Albain,K. S.Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 ;23(1):24-29
West,H.; Albain,K. S.Current standards and ongoing controversies in the management of locally advanced non-small cell lung cancer Seminars in oncology 2005 ;32(3):284-292
Blackhall,F. H.; Shepherd,F. A.; Albain,K. S.Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer : a realistic goal? Treatments in respiratory medicine 2005 ;4(2):71-84
Gandara,D. R.; Vallieres,E.; Gaspar,L. E.; Kelly,K.; Albain,K. S.; Herbst,R. S.,Jr; Lara,P. N.,Jr; Mack,P.; Gumerlock,P. H.; Crowley,J. J.Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: rationale for consolidation docetaxel therapy Clinical Lung Cancer 2005 ;7 Suppl 3:S93-7
Gaspar,L. E.; Chansky,K.; Albain,K. S.; Vallieres,E.; Rusch,V.; Crowley,J. J.; Livingston,R. B.; Gandara,D. R.Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 ;23(13):2955-2961
Albain,K. S.; de la Garza Salazar,J.; Pienkowski,T.; Aapro,M.; Bergh,J.; Caleffi,M.; Coleman,R.; Eiermann,W.; Icli,F.; Pegram,M.; Piccart,M.; Snyder,R.; Toi,M.; Hortobagyi,G. N.Reducing the global breast cancer burden: the importance of patterns of care research Clinical Breast Cancer 2005 ;6(5):412-420
Hortobagyi,G. N.; de la Garza Salazar,J.; Pritchard,K.; Amadori,D.; Haidinger,R.; Hudis,C. A.; Khaled,H.; Liu,M. C.; Martin,M.; Namer,M.; O'Shaughnessy,J. A.; Shen,Z. Z.; Albain,K. S.; ABREAST InvestigatorsThe global breast cancer burden: variations in epidemiology and survival Clinical Breast Cancer 2005 ;6(5):391-401
Grunenwald,D. H.; Albain,K. S.The potential role of surgery after induction treatment SEMINARS IN RADIATION ONCOLOGY 2004 ;14(4):335-339
Edelman,M. J.; Clark,J. I.; Chansky,K.; Albain,K.; Bhoopalam,N.; Weiss,G. R.; Giguere,J. K.; Kelly,K.; Crowley,J.; Gandara,D. R.Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel Clinical cancer research : an official journal of the American Association for Cancer Research 2004 ;10(15):5022-5026
Fabian,C. J.; Kimler,B. F.; Anderson,J.; Tawfik,O. W.; Mayo,M. S.; Burak,W. E.,Jr; O'Shaughnessy,J. A.; Albain,K. S.; Hyams,D. M.; Budd,G. T.; Ganz,P. A.; Sauter,E. R.; Beenken,S. W.; Grizzle,W. E.; Fruehauf,J. P.; Arneson,D. W.; Bacus,J. W.; Lagios,M. D.; Johnson,K. A.; Browne,D.Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator Clinical cancer research : an official journal of the American Association for Cancer Research 2004 ;10(16):5403-5417
Albain,K. S.Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials Journal of the National Cancer Institute 2004 ;96(24):1801-1804
Lara,P. N.,Jr; Gumerlock,P. H.; Mack,P. C.; Lau,D. H.; Gandour-Edwards,R.; Edelman,M. J.; Albain,K. S.; Law,L. Y.; Longmate,J.; Frankel,P.; Reddy,G. P.; Israel,V.; Doroshow,J. H.; Gandara,D. R.Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trial Clinical Lung Cancer 2004 ;6(2):102-107
Kris,M. G.; Natale,R. B.; Herbst,R. S.; Lynch,T. J.,Jr; Prager,D.; Belani,C. P.; Schiller,J. H.; Kelly,K.; Spiridonidis,H.; Sandler,A.; Albain,K. S.; Cella,D.; Wolf,M. K.; Averbuch,S. D.; Ochs,J. J.; Kay,A. C.Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial JAMA : the journal of the American Medical Association 2003 ;290(16):2149-2158
Hillner,B. E.; Ingle,J. N.; Chlebowski,R. T.; Gralow,J.; Yee,G. C.; Janjan,N. A.; Cauley,J. A.; Blumenstein,B. A.; Albain,K. S.; Lipton,A.; Brown,S.; American Society of Clinical OncologyAmerican Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 ;21(21):4042-4057
Gandara,D. R.; Chansky,K.; Albain,K. S.; Leigh,B. R.; Gaspar,L. E.; Lara,P. N.,Jr; Burris,H.; Gumerlock,P.; Kuebler,J. P.; Bearden,J. D.,3rd; Crowley,J.; Livingston,R.; Southwest Oncology GroupConsolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504 Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 ;21(10):2004-2010
Juhasz,A.; Frankel,P.; Cheng,C.; Rivera,H.; Vishwanath,R.; Chiu,A.; Margolin,K.; Yen,Y.; Newman,E. M.; Synold,T.; Wilczynski,S.; Lenz,H. J.; Gandara,D.; Albain,K. S.; Longmate,J.; Doroshow,J. H.Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products Journal of clinical laboratory analysis 2003 ;17(5):184-194
Eberhardt,W. E.; Albain,K. S.; Pass,H.; Putnam,J. B.; Gregor,A.; Assamura,H.; Mornex,F.; Senan,S.; Belderbos,J.; Westeel,V.; Thomas,M.; Van Schil,P.; Vansteenkiste,J.; Manegold,C.; Mirimanoff,R. O.; Stuschke,M.; Pignon,J.; Rocmans,P.; Shepherd,F. A.Induction treatment before surgery for non-small cell lung cancer Lung cancer (Amsterdam, Netherlands) 2003 ;42 Suppl 1:S9-14
Albain,K. S.; Crowley,J. J.; Turrisi,A. T.,3rd; Gandara,D. R.; Farrar,W. B.; Clark,J. I.; Beasley,K. R.; Livingston,R. B.Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019 Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 ;20(16):3454-3460
Stradling,B.; Albain,K.; Siziopikou,K.; Wilcoxson,L.; Aranha,G. V.; Shayani,V.; Fisher,S.; Grabram,S.Positive immunohistochemistry in histologically negative sentinel noeds: affect on adjuvant therapy in early-stage breast cancer. Surgical Rounds 2002 ;25(11):535-542
Clark,J. I.; Albain,K. S.Combined modality therapy for early stage operable and locally advanced potentially resectable non-small cell lung carcinoma Cancer treatment and research 2001 ;105:149-170
Clark,J. I.; Kancharla,K.; Qamar,R.; Fisher,S.; Hantel,A.; Panganiban,J.; Millbrandt,L.; Albain,K. S.Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer Lung cancer (Amsterdam, Netherlands) 2001 ;34(2):271-277
Unger,J. M.; Flaherty,L. E.; Liu,P. Y.; Albain,K. S.; Sondak,V. K.Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials Cancer 2001 ;91(6):1148-1155
Hillner,B. E.; Ingle,J. N.; Berenson,J. R.; Janjan,N. A.; Albain,K. S.; Lipton,A.; Yee,G.; Biermann,J. S.; Chlebowski,R. T.; Pfister,D. G.American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 ;18(6):1378-1391
Gotay,C. C.; Moinpour,C. M.; Moody-Thomas,S.; Gritz,E. R.; Albain,K. S.; DeAntoni,E.; Hansen,L.; Ganz,P. A.Behavioral science research in the cooperative group setting: the Southwest Oncology Group experience Journal of the National Cancer Institute 2000 ;92(17):1381-1387
Albain,K. S.Induction chemotherapy or chemoradiotherapy before surgery for non-small-cell lung cancer Current oncology reports 2000 ;2(1):54-63